TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource’s AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats.
AlloFuse products comprise 100% demineralized cortical bone and can be used in a range of spine and orthopaedic procedures.
AlloSource launched AlloFuse Cortical Fiber and Fiber Boat allografts in 2Q16.
TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource's AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats.
AlloFuse products comprise 100% demineralized cortical bone and can be used in a range of spine and orthopaedic procedures.
AlloSource...
TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource’s AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats.
AlloFuse products comprise 100% demineralized cortical bone and can be used in a range of spine and orthopaedic procedures.
AlloSource launched AlloFuse Cortical Fiber and Fiber Boat allografts in 2Q16.
Copy to clipboard 
